Welcome to the International Congress on Oncology and Cancer

Convergence of Technology and Biology: Shaping the Future of Cancer Care

Dear Colleagues and Distinguished Guests,

On behalf of the organizing committee, it is our great pleasure to welcome you to the International Congress on Oncology and Cancer, taking place in the heart of Paris, France, on March 13-14, 2025.

This year's congress theme, "Convergence of Technology and Biology: Shaping the Future of Cancer Care," encapsulates the revolutionary intersection where cutting-edge technology meets ground-breaking biological research in oncology. As we stand at this pivotal juncture, we have an unprecedented opportunity to redefine cancer research, diagnosis, and treatment paradigms.

Our meticulously curated scientific program will explore how emerging technologies such as artificial intelligence, nanotechnology, and advanced imaging are synergizing with breakthroughs in cancer biology, genomics, and immunology. This convergence is not only advancing our understanding of cancer at a molecular level but also paving the way for more precise, personalized, and effective treatment strategies.

Key focus areas of our congress include:

1. AI-driven diagnostics and predictive modeling in oncology

2. Nanotechnology applications in targeted therapeutics and molecular imaging

3. Next-generation sequencing and its impact on precision oncology

4. Bioengineering approaches in cancer immunotherapy

5. Digital health technologies for patient monitoring and care management

6. Computational biology in deciphering cancer pathways and drug discovery

7. Integrative multi-omics approaches in cancer research

Through keynote presentations, plenary sessions, and interactive panel discussions, we aim to foster a rich dialogue that bridges technological innovation with biological insights. The congress will also feature oral and poster presentations selected from peer-reviewed abstracts, providing a platform for both established investigators and emerging scientists to showcase their latest research.

We cordially invite clinicians, researchers, bioinformaticians, and industry leaders to join us in this vital conversation. Your expertise and diverse perspectives are crucial as we collectively work towards a future where the synergy between technology and biology overcomes the multifaceted challenges posed by cancer.

Set against the backdrop of Paris, a city renowned for its contributions to science and culture, this congress offers not only scientific excellence but also a unique opportunity for networking and collaboration in an inspiring environment.

We look forward to your participation in what promises to be an enlightening and collaborative event. Together, let us shape the future of cancer care and pave the way for transformative advancements in oncology.

Warm Regards,

Opulent Conferences

Chair, Organizing Committee

International Congress on Oncology and Cancer

Cancer 2025: International Congress on Oncology and Cancer

Convergence of Technology and Biology: Shaping the Future of Cancer Care

Conference Details

Date: March 13-14, 2025

Location: Paris, France

About the Conference

The International Congress on Oncology and Cancer is a premier global event bringing together leading researchers, clinicians, and industry experts in the field of oncology. This year's theme, "Convergence of Technology and Biology: Shaping the Future of Cancer Care," reflects the cutting-edge developments at the intersection of technological innovation and biological research in cancer treatment and prevention.

Conference Highlights

Keynote Speakers: World-renowned experts will deliver thought-provoking presentations on the latest breakthroughs in cancer research and treatment.

Plenary Sessions: In-depth discussions on major advancements across various cancer types and treatment modalities.

Interactive Workshops: Hands-on sessions focusing on new technologies and methodologies in cancer research and clinical practice.

Poster Presentations: Showcasing cutting-edge research from established scientists and promising young researchers.

Networking Opportunities: Dedicated sessions for professional networking and collaboration building.

Exhibition Area: Featuring the latest technologies, drugs, and services in oncology from leading companies and startups.

Sessions and Tracks

1. Cancer Biology and Genetics

2. Cancer Immunotherapy

3. Clinical Oncology

4. Precision Medicine in Cancer

5. Cancer Epidemiology and Prevention

6. Pediatric Oncology

7. Hematologic Malignancies

8. Cancer Screening and Early Detection

9. Surgical Oncology

10. Supportive Oncology and Palliative Care

11. Radiation Oncology

12. Oncology Nursing

13. Psycho-Oncology

14. Cancer Biomarkers

15. Cancer Pharmacology

16. Global Oncology

17. Nutrition and Cancer

18. Ethical Issues in Oncology

19. Cancer Survivorship and Rehabilitation

20. Emerging Technologies in Cancer Research

Intended Attendees

1. Oncologists and Cancer Specialists

2. Research Scientists and Academics

3. Bioinformaticians and Data Scientists

4. Pharmaceutical and Biotech Professionals

5. Healthcare Technologists and Engineers

6. Clinical Trial Coordinators

7. Healthcare Policy Makers

8. Postgraduate Students and Early Career Researchers

9. Radiation Oncologists

10. Surgical Oncologists

11. Pediatric Oncologists

12. Hematologists

13. Oncology Nurses

14. Palliative Care Specialists

15. Cancer Epidemiologists

16. Geneticists and Genomics Researchers

17. Immunologists

18. Pathologists

19. Radiologists

20. Medical Physicists

21. Psycho-Oncologists

22. Nutritionists specializing in Oncology

23. Bioethicists

24. Cancer Rehabilitation Specialists

25. Health Economists

26. Cancer Patient Advocates

27. Public Health Professionals

28. Biomarker Development Specialists

29. AI and Machine Learning Experts in Healthcare

30. Cancer Registry Professionals

Abstract Submission

We invite researchers to submit abstracts for oral and poster presentations. The key note abstract submission deadline is December 04, 2024. For submission guidelines and more information, please visit our Abstract Submission page:.https://opulentconferences.com/abstract-submission.

Registration

Early bird registration is now open. Take advantage of reduced rates by registering before December 18, 2024. For registration fees and to secure your spot, please visit our Registration page https://opulentconferences.com/registration/cancer.

Accommodation

We have partnered with several hotels near the conference venue to offer special rates for attendees. For more information and booking, please visit our Accommodation page and choose packages.

About Paris

Paris, the City of Light, offers a unique blend of history, culture, and scientific innovation. Attendees will have the opportunity to explore world-famous landmarks and enjoy the city's renowned cuisine during their stay.

Contact Information

For any queries regarding the conference, please contact:

Email: oncologycongress@opulentmeetings.com

Phone: UK: +44-2045774235

USA: +1-9292351191

WhatsApp us: +44 1633 494617

We look forward to welcoming you to this groundbreaking event in Paris, where together we will shape the future of cancer care through the powerful convergence of technology and biology.

1. Cancer Biology and Genetics:

Research into the intricate mechanisms underlying cancer development and progression, exploring genetic mutations, oncogenes, and tumor suppressor genes. Discussions will focus on molecular pathways, cellular interactions, and genomic profiling to elucidate cancer biology's complexities and potential therapeutic targets.

2. Cancer Immunotherapy:

Explore groundbreaking advancements in leveraging the immune system to combat cancer. Topics include immune checkpoint inhibitors, CAR-T cell therapy, and vaccine-based approaches. Emphasis will be on enhancing immune responses against tumors and overcoming immunosuppressive factors in the tumor microenvironment.

3. Clinical Oncology:

Clinical oncology highlighting the latest treatments and management strategies in medical, surgical, and radiation oncology. Discussions will cover clinical trials, treatment guidelines, and multidisciplinary approaches to personalized cancer care, aiming to improve patient outcomes and quality of life.

4. Precision Medicine in Cancer:

Precision medicine focuses on tailoring cancer treatment based on individual genetic, molecular, and clinical profiles. Topics include biomarker-driven therapies, targeted therapies, and genomic sequencing technologies. The track will explore precision oncology's potential to optimize treatment efficacy and minimize adverse effects.

5. Cancer Epidemiology and Prevention:

Analyze epidemiological trends, risk factors, and preventive measures for various cancer types. Discussions will address population-based studies, screening programs, lifestyle modifications, and public health initiatives aimed at reducing cancer incidence and mortality.

6. Pediatric Oncology:

Dedicated to childhood cancers, covering diagnosis, treatment modalities, survivorship care, and psychosocial support for pediatric patients and their families. Topics include pediatric clinical trials, genetic predispositions, and advances in pediatric oncology research.

7. Hematologic Malignancies:

Focus on blood cancers such as leukemia, lymphoma, and myeloma. Discussions will include novel therapies, stem cell transplantation, and molecular diagnostics, aiming to improve outcomes for patients with hematologic malignancies.

8. Cancer Screening and Early Detection:

Highlighting advancements in screening technologies, early diagnostic methods, and biomarker identification. Discussions will address the importance of early detection in improving cancer prognosis and treatment outcomes.

9. Surgical Oncology:

Explore innovative surgical techniques, minimally invasive procedures, and robotic-assisted surgeries in cancer treatment. Topics include surgical innovations, perioperative care, and outcomes research in surgical oncology.

10. Supportive Oncology and Palliative Care:

Focus on enhancing the quality of life for cancer patients through supportive care interventions, symptom management, and end-of-life care. Discussions will cover palliative care models, patient-centered approaches, and psychosocial support for cancer patients and caregivers.

11. Radiation Oncology:

Covering advances in radiotherapy techniques, treatment planning, and radiation delivery technologies. Topics include stereotactic radiosurgery, proton therapy, and radiobiology advancements aimed at optimizing cancer treatment outcomes while minimizing side effects.

12. Oncology Nursing:

Discuss the critical role of oncology nurses in patient care, education, and support throughout the cancer continuum. Topics include nursing interventions, patient advocacy, and advancements in oncology nursing practice.

13. Psycho-Oncology:

Addressing the psychological, emotional, and social impact of cancer diagnosis and treatment on patients, families, and caregivers. Discussions will cover psychotherapeutic interventions, coping strategies, and psychosocial oncology research.

14. Cancer Biomarkers:

Explore the role of biomarkers in cancer diagnosis, prognosis, treatment selection, and monitoring. Topics include emerging biomarker technologies, liquid biopsies, and their integration into clinical practice for personalized cancer care.

15. Cancer Pharmacology:

Discuss pharmacological interventions, drug development strategies, and mechanisms of action for anticancer agents. Topics include chemotherapy, targeted therapies, immunotherapy drugs, and pharmacogenomics in oncology.

16. Global Oncology:

Addressing disparities in cancer care, access to treatment, and global health initiatives in oncology. Discussions will focus on international collaborations, health policy implications, and strategies to improve cancer outcomes worldwide.

17. Nutrition and Cancer:

Explore the impact of diet, nutrition, and lifestyle factors on cancer risk, prevention, and treatment outcomes. Topics include dietary interventions, nutritional support for cancer patients, and the role of nutrition in cancer survivorship.

18. Ethical Issues in Oncology:

Examine ethical dilemmas in cancer research, clinical trials, treatment decisions, and end-of-life care. Discussions will address patient autonomy, informed consent, equity in access to care, and ethical considerations in oncology practice.

19. Cancer Survivorship and Rehabilitation:

Focus on long-term care strategies for cancer survivors, including survivorship care plans, rehabilitation therapies, and psychosocial support. Topics will cover survivorship issues, survivorship research, and improving quality of life post-treatment.

20. Emerging Technologies in Cancer Research:

Highlighting cutting-edge technologies such as artificial intelligence, machine learning, and genomic sequencing in advancing cancer research and personalized medicine. Discussions will explore their potential applications in early detection, treatment optimization, and precision oncology.

Oncology Market Analysis: Trends and Projections Towards 2025

Overview

The global oncology market continues to evolve rapidly, driven by technological advancements, biological insights, and changing demographics. As we approach 2025, the landscape of cancer care is being reshaped by innovative therapies, precision medicine, and digital health solutions.

Market Size and Growth

The global oncology market is projected to reach $424.6 billion by 2025, growing at a CAGR of 7.7% from 2023 to 2025. This growth is primarily increased by:

1. Rising cancer incidence due to aging populations and lifestyle factors

2. Increasing adoption of targeted and immunotherapies

3. Advancements in diagnostic technologies

4. Expanding access to cancer care in emerging markets

Key Market Segments

Therapeutics

Targeted Therapies: Expected to dominate the market, with a projected market share of 46% by 2025.

Immunotherapy: Continuing rapid growth at a CAGR of 13.6%, particularly CAR-T cell therapies and checkpoint inhibitors.

Precision Medicine: Personalized treatments based on genetic profiling are becoming standard of care, with a market expected to reach $84.6 billion by 2025.

Diagnostics

Liquid Biopsies: Market projected to reach $5.8 billion by 2025, with a CAGR of 28.9%.

Molecular Diagnostics: Essential for targeted therapy selection, growing at 8.7% annually.

AI-powered Imaging: Enhancing early detection and treatment planning, with a market size expected to reach $4.9 billion by 2025.

Technological Trends Shaping the Market

Artificial Intelligence in Drug Discovery: AI-driven platforms are accelerating the identification of novel drug targets and lead compounds, potentially reducing drug development timelines by 30-50%.

Big Data and Real-World Evidence: Integration of diverse data sources is enabling more efficient clinical trials and post-market surveillance, with the healthcare analytics market growing at a CAGR of 23.5%.

Digital Therapeutics: Mobile apps and wearables for symptom management and treatment adherence are gaining traction, with the market expected to reach $8.7 billion by 2025, growing at a CAGR of 21.4%.

3D-Printed Personalized Treatments: Custom-made implants and drug delivery systems are emerging as a promising field, with the 3D printing in healthcare market growing at a CAGR of 18.2%.

Biological Advancements Driving Innovation

Precision Oncology: The market for next-generation sequencing in oncology is projected to grow at a CAGR of 15.8% through 2025.

Epigenetic Therapies: A new frontier in cancer treatment, with the market expected to reach $9.3 billion by 2025, growing at a CAGR of 17.5%.

Microbiome-based Approaches: Growing evidence of the microbiome's role in cancer is spurring new therapeutic strategies, with the cancer microbiome market projected to grow at a CAGR of 26.8%.

Gene Editing: CRISPR and other gene-editing technologies are opening new avenues for cell therapies and target identification, with the market expected to reach $10.7 billion by 2025, growing at a CAGR of 23.2%.

Market Challenges and Opportunities

Drug Pricing and Reimbursement: High costs of innovative therapies remain a significant barrier to access, with cancer drugs accounting for 27% of global pharmaceutical spending.

Regulatory Landscape: Evolving regulations around personalized medicine and AI in healthcare present both challenges and opportunities, with 42% of oncology professionals citing regulatory complexity as a major hurdle.

Healthcare Disparities: Addressing global inequities in cancer care access remains a critical challenge and market opportunity, with only 5% of global cancer resources spent in low- and middle-income countries.

Clinical Trial Innovation: Decentralized and adaptive trial designs are becoming more prevalent, potentially reducing drug development costs by 15-20%.

Regional Market Dynamics

North America: Largest market share at 42%, driven by high healthcare expenditure and early adoption of innovative therapies.

Europe: Strong focus on precision medicine and collaborative research initiatives, holding 28% of the global market share.

Asia-Pacific: Fastest-growing region with a CAGR of 9.6%, with increasing investment in healthcare infrastructure and rising cancer awareness.

Emerging Markets: Represent a significant growth opportunity, with a projected CAGR of 11.3%, driven by improving access to basic and advanced cancer treatments.

Future Outlook

As we move towards 2025, the oncology market is poised for transformative changes. The convergence of technology and biology is expected to yield more effective, personalized, and accessible cancer care solutions. Key areas to watch include:

1. Integration of multi-omics data for more precise treatment selection

2. Advancement of cell and gene therapies beyond hematological cancers

3. Development of novel drug delivery systems for enhanced efficacy and reduced toxicity

4. Expansion of value-based care models in oncology

This dynamic landscape presents both challenges and opportunities for stakeholders across the oncology ecosystem, from researchers and clinicians to policymakers and industry leaders.

Conclusion: The Significance of Cancer 2025 in Paris, France

The decision by Opulent Conferences to host the Cancer 2025 conference in Paris, France, is a strategic choice that aligns perfectly with the current trends and future directions of the global oncology market. Here's why:

1. Research Excellence: Paris is home to world-renowned research institutions and cancer centers, making it an ideal location to showcase cutting-edge oncology research. The city's rich scientific heritage provides an inspiring backdrop for the conference's focus on the convergence of technology and biology in cancer care.

2. European Market Insights: With Europe being a key player in the global oncology market, particularly in precision medicine and collaborative research initiatives, hosting the conference in Paris allows attendees to gain firsthand insights into European market dynamics and regulatory landscapes.

3. Global Accessibility: Paris's central location and excellent connectivity make it easily accessible for attendees from around the world, facilitating truly global discussions on oncology trends and challenges.

4. Innovation Hub: The city has emerged as a hub for biotech and health tech startups, aligning with the conference's emphasis on technological innovations in cancer care. This setting provides opportunities for fruitful interactions between researchers, clinicians, and industry innovators.

5. Interdisciplinary Approach: The comprehensive market analysis presented here underscores the need for interdisciplinary collaboration in advancing cancer care. Paris, with its diverse scientific community, provides an ideal environment for fostering such collaborations.

6. Policy and Funding Landscape: France's commitment to cancer research and universal healthcare offers a unique perspective on addressing market challenges such as drug pricing and healthcare disparities, topics of critical importance as highlighted in our analysis.

By bringing together global experts in this scientifically and culturally rich setting, the Cancer 2025 conference in Paris is poised to be a catalyst for transformative discussions and collaborations. It offers a unique opportunity for attendees to engage with the latest research, market trends, and technological advancements shaping the future of oncology.

The research-oriented perspective of this market analysis reflects the conference's commitment to bridging the gap between scientific discoveries and market applications. By understanding the complex interplay of biological advancements, technological innovations, and market dynamics, participants will be better equipped to drive progress in cancer care towards 2025 and beyond.

As we stand at the cusp of a new era in oncology, marked by unprecedented integration of technology and biology, the Cancer 2025 conference in Paris promises to be a pivotal event in shaping the future of cancer research, treatment, and care delivery.

Take Away from Cancer 2025: International Congress on Oncology and Cancer

Knowledge and Insights

Advanced Research: Gain insights into the latest advancements in cancer biology, diagnostics, and therapeutics from world-renowned experts.

Technological Innovations: Learn about emerging technologies shaping the future of cancer care, including AI, precision medicine, and digital health solutions.

Clinical Perspectives: Understand the practical implications of research findings and how they translate to improved patient care.

Global Perspectives: Benefit from diverse viewpoints on cancer care challenges and solutions from experts around the world.

Networking Opportunities

Global Connections: Connect with oncology professionals from numerous countries, including leading researchers, clinicians, and industry experts.

Collaboration Prospects: Identify potential research partners or clinical collaborators.

Career Development: Engage with potential employers or employees in the oncology field.

Professional Development

Skill Enhancement Workshops: Participate in hands-on workshops on topics such as grant writing, publication strategies, and new research methodologies.

Career Guidance Sessions: Attend specialized sessions for early-career researchers and clinicians on career development in oncology.

Recognition and Awards

Participation Certificate

All registered attendees will receive a digital Participation Certificate for webinar and hard copy for In-person, acknowledging their attendance at this prestigious international conference.

Best Poster Awards

Categories:

Basic Science Research

Clinical Research

Translational Research

Public Health and Epidemiology

Recognition:

Winners in each category will receive a certificate and recognition during the awards ceremony.

Evaluation Criteria: Scientific merit, innovation, methodology, presentation quality, and potential impact on cancer care.

Young Researcher Forum (YRF) Awards

Eligibility: Researchers aged 32 or under as of March 13, 2025.

Categories:

PhD Students

Postdoctoral Researchers

Early Career Investigators

Awards

Best Oral Presentation: Certificate and recognition

Best Poster Presentation: Certificate and recognition

People's Choice Award: Certificate (voted by conference attendees)

Benefits:

Dedicated YRF networking session with senior researchers and industry leaders

Mentorship matching with established researchers in their field

Opportunity to chair a conference session

Post-Conference Resources

Digital Access: Complimentary access to recorded sessions and presentations for a limited time post-conference.

Networking Platform: Continued access to the conference networking platform for a period post-event.

Resource Library: Access to presentation slides, posters, and supplementary materials shared by speakers and presenters.

Experience Paris: The City of Science and Culture

While attending Cancer 2025, you'll have the opportunity to immerse yourself in the rich scientific and cultural atmosphere of Paris. Although the conference does not organize specific cultural tours or events, your visit to this iconic city offers unique benefits:

1. Scientific Heritage: Paris has a long-standing tradition of scientific excellence, particularly in medical research. The city is home to renowned institutions like the Institut Curie and the French National Institute of Health and Medical Research (INSERM), fostering an environment of innovation and discovery.

2. Networking in an Inspiring Setting: The conference venue and surrounding areas provide an inspiring backdrop for informal discussions and networking. Paris's cafes and public spaces have long been hubs of intellectual exchange, offering the perfect setting for continuing conversations beyond the conference halls.

3. Global Perspective: As an international hub, Paris attracts researchers and clinicians from around the world. This diverse environment enhances the global perspective of the conference, allowing for rich cross-cultural scientific exchanges.

4. Innovation Ecosystem: Paris is emerging as a key player in the biotech and healthtech startup scene. The city's innovation ecosystem complements the conference's focus on advancing cancer research and treatment.

5. Work-Life Balance: While the conference schedule is full of valuable sessions, being in Paris serves as a reminder of the importance of work-life balance in the demanding field of oncology. The city's ambiance can provide a refreshing perspective and inspiration for your work.

6. Accessible Location: Paris's central location and excellent transportation links make it easy for attendees from across Europe and around the world to participate, fostering a truly global gathering of oncology professionals.

While your primary focus will be the rich scientific program of Cancer 2025, the unique setting of Paris adds an extra dimension to your conference experience, potentially inspiring new ideas and collaborations in the fight against cancer.

Attending Cancer 2025 in Paris offers a unique blend of scientific excellence, professional growth, and cultural enrichment. Whether you are a seasoned oncology professional or an early-career researcher, this conference provides valuable opportunities to learn, connect, and contribute to the future of cancer care.